Context: Caffeic acid phenethyl ester (CAPE), isolated from honeybee propolis, has pharmacological applications. A synthesized CAPE derivative, p-nitro-caffeic acid phenethyl ester (CAPE-NO 2 ), showed similar activities with CAPE. The pharmacological activities of CAPE and CAPE-NO 2 are related to their absorption properties. Objective: To understand the pharmacokinetic profiles of CAPE and CAPE-NO 2 in rats and investigate the absorption mechanisms and effects on P-glycoprotein in Caco-2 cells. Materials and methods: The pharmacokinetic profiles of CAPE and CAPE-NO 2 were obtained after oral administration (10 mg/kg) to rats. Transport studies of CAPE and CAPE-NO 2 (5, 10, 20 lM) were performed in Caco-2 cell model. P-gp activities were assayed by rhodamine 123 cellular retention. Expression of P-gp was determined after the cells were administrated with CAPE and CAPE-NO 2 (5, 20 lM) for 48 and 72 h. Results: The AUC (0Àt) of CAPE-NO 2 (3239.9 ± 352 ng  h/mL) was two-time greater than CAPE (1659.6 ± 152 ng  h/mL) in rats. The P app values of CAPE and CAPE-NO 2 were (4.86 ± 0.90)  10 À6